BioSpace News Archive

Business

Premas, IncellDx Ink India Distribution Agreement

The commercial partnership brings the power of cell by cell multiplex diagnostics for solid tumors carcinomas that can now be analyzed for molecular and protein biomarkers by flow cytometry.

January 17, 2018
·
2 min read
Business

Synpromics Appoints Sarah Haecker Meeks, PhD as Vice President of Business Development

Dr. Haecker Meeks brings a deep expertise in emerging technologies and business strategy focused on the design and development of gene medicines and will lead business development for the company.

January 17, 2018
·
4 min read
FDA

Asuragen Obtains CE Mark of QuantideX qPCR BCR-ABL Kits on Roche Diagnostics cobas z 480 Analyzer

Asuragen announced that it has expanded its CE mark of the QuantideX qPCR BCR-ABL IS Kit and QuantideX qPCR BCR-ABL minor Kit to include clinical use on the Roche Diagnostics cobas z 480 Analyzer.

January 17, 2018
·
3 min read
Business

Glythera Appoints Chief Scientific Officer and Strengthens SAB

Dr Lutz will lead the advancement of Glythera’s portfolio of Antibody Drug Conjugates (ADCs) in the treatment of difficult-to-treat cancers.

January 17, 2018
·
2 min read
Drug Development

OBI Pharma Announces FDA Clearance of IND Application for a Phase 1 Study of a Monoclonal Antibody Cancer Immunotherapy (OBI-888).

OBI plans to enroll patients with locally advanced or metastatic solid tumors of all types.

January 17, 2018
·
3 min read
Policy

Outpost Medicine Announces Acceptance of Two Investigational New Drug Applications for OP-687 by U.S. FDA

The FDA DBRUP and the DGIEP accepted the INDs for the treatment of overactive bladder and iIBS, respectively.

January 17, 2018
·
2 min read
Policy

Hill-Rom’s Tele-Ophthalmology Services Provider, RetinaVue, P.C., Receives Joint Commission Accreditation

The Joint Commission’s Gold Seal of Approval for Ambulatory Health Care Accreditation by demonstrating continuous compliance with its nationally recognized standards.

January 17, 2018
·
4 min read
Drug Development

BioLineRx Announces Partial Monotherapy Results From Phase IIa COMBAT Study in Pancreatic Cancer

The partial results from the BL-8040 monotherapy portion of the COMBAT trial show that BL-8040 was safe and well-tolerated.

January 17, 2018
·
8 min read
Drug Development

Curis Announces Initiation of Phase 1 Trial of CA-4948, a Small Molecule Inhibitor of IRAK4 Kinase in Patients with Lymphoma

The Phase 1 study is designed to evaluate the safety, tolerability, and pharmacokinetic profile of CA-4948.

January 17, 2018
·
4 min read
Business

X-Chem Enters Expanded Global Drug Discovery and Technology Transfer Collaboration with AstraZeneca

The new agreement focuses on the synthesis and delivery of custom libraries to AstraZeneca as well as the transfer of the DEX platform, allowing for in-house screening of DNA-encoded libraries at AstraZeneca.

January 17, 2018
·
3 min read